STAT Plus: Pharmalittle: Tension in the Verily-Dexcom tango; not so fast on the Pfizer-GSK spinoff

GlaxoSmithKline hasn’t made plans to pursue an IPO of the consumer-health company it set up with Pfizer, a top executive said, distancing himself from remarks made by Pfizer’s chief executive a…

Click to view original post